Advantages and disadvantages of disulfiram coadministered with popular addictive substances.

Kleczkowska, Patrycja; Sulejczak, Dorota; Zaremba, Malgorzata

Kleczkowska, Patrycja; Sulejczak, Dorota; Zaremba, Malgorzata.

Affiliation

Kleczkowska P; Department of Pharmacodynamics, Centre for Preclinical Research (CBP), Medical University of Warsaw, 02-097, Warsaw, Poland; Military Institute of Hygiene and Epidemiology, 01-163, Warsaw, Poland. Electronic address: hazufiel@wp.pl.
Sulejczak D; Department of Experimental Pharmacology, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106, Warsaw, Poland.
Zaremba M; Military Institute of Hygiene and Epidemiology, 01-163, Warsaw, Poland; Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research (CBP), Medical University of Warsaw, 02-097, Warsaw, Poland.

Eur J Pharmacol ; 904: 174143, 2021 Aug 05.

Article de En | MEDLINE | ID: mdl-33971180

Sujet(s)
Mots clés

Addiction; Disulfiram; Drug abuse; Interaction; Toxicity

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Troubles liés à une substance / Disulfirame / Inhibiteurs de l'acétaldéhyde déshydrogénase Limites: Animals / Humans Langue: En Journal: Eur J Pharmacol Année: 2021 Type de document: Article Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google